Skip to search formSkip to main contentSkip to account menu

ROSE-010

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Gut peptides in gastrointestinal motility and mucosal permeability
Gut regulatory peptides, such as neuropeptides and incretins, play important roles in hunger, satiety and gastrointestinal… 
2016
2016
GLP-1 acts at myenteric neurons to inhibit motility in humans: results of in vivo motility studies and in vitro characterization of responses to GLP-1 and ROSE-010 : GLP-1 and digestive motility
Background: Glucagon-like peptide-1 (GLP-1) is secreted from L-cells after nutrient ingestion, inhibiting motility. Aims: To… 
2016
2016
452 GLP-1 Inhibits Prandial Antro-Duodeno-Jejunal Motility in Humans: Native GLP-1 Compared With Analogue ROSE-010 In Vitro
2012
2012
755 Effect of ROSE-010 on Gastrointestinal Motor Functions in Female Patients With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
2010
2010
S1316 Patient Willingness to use ROSE-010: A Subcutaneous (SC) GLP-1 Analogue for IBS Pain Episodes
Review
2009
Review
2009
GLP-1: Broadening the incretin concept to involve gut motility
2009
2009
Pulmonary Insufflation of ROSE-010 (GLP-1 Peptide Analogue) Completely Suppresses the MMC in the Conscious Rat: Comparison with the Intravenous and Subcutaneous Routes
INTRODUCTION: Subcutaneous administration of ROSE-010, a GLP-1 analogue, reduces bowel spasm and relieves acute pain in patients… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)